These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34870901)

  • 1. Interactions between host genetics and gut microbiota determine susceptibility to CNS autoimmunity.
    Montgomery TL; Künstner A; Kennedy JJ; Fang Q; Asarian L; Culp-Hill R; D'Alessandro A; Teuscher C; Busch H; Krementsov DN
    Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27516-27527. PubMed ID: 33077601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naringenin confers protection against experimental autoimmune encephalomyelitis through modulating the gut-brain axis: A multiomics analysis.
    Liu Z; Sun M; Jin C; Sun X; Feng F; Niu X; Wang B; Zhang Y; Wang J
    J Nutr Biochem; 2023 Dec; 122():109448. PubMed ID: 37741298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feeding the gut microbiome: impact on multiple sclerosis.
    Bronzini M; Maglione A; Rosso R; Matta M; Masuzzo F; Rolla S; Clerico M
    Front Immunol; 2023; 14():1176016. PubMed ID: 37304278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the Gut-Brain Axis for the Control of CNS Inflammatory Demyelination: Immunomodulation by
    Erturk-Hasdemir D; Ochoa-Repáraz J; Kasper DL; Kasper LH
    Front Immunol; 2021; 12():662807. PubMed ID: 34025663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variations in diet cause alterations in microbiota and metabolites that follow changes in disease severity in a multiple sclerosis model.
    Libbey JE; Sanchez JM; Doty DJ; Sim JT; Cusick MF; Cox JE; Fischer KF; Round JL; Fujinami RS
    Benef Microbes; 2018 Apr; 9(3):495-513. PubMed ID: 29380645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latent-period stool proteomic assay of multiple sclerosis model indicates protective capacity of host-expressed protease inhibitors.
    Gonzalez CG; Tankou SK; Cox LM; Casavant EP; Weiner HL; Elias JE
    Sci Rep; 2019 Aug; 9(1):12460. PubMed ID: 31462662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral vancomycin treatment suppresses gut trypsin activity and preserves intestinal barrier function during EAE.
    Bianchimano P; Iwanowski K; Smith EM; Cantor A; Leone P; Bongers G; Gonzalez CG; Hongsup Y; Elias J; Weiner HL; Clemente JC; Tankou SK
    iScience; 2023 Nov; 26(11):108143. PubMed ID: 37915599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perivascular B cells link intestinal angiogenesis to immunity and to the gut-brain axis during neuroinflammation.
    Peter B; Rebeaud J; Vigne S; Bressoud V; Phillips N; Ruiz F; Petrova TV; Bernier-Latmani J; Pot C
    J Autoimmun; 2024 Jul; 148():103292. PubMed ID: 39067313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebellar pathology in multiple sclerosis and experimental autoimmune encephalomyelitis: current status and future directions.
    Maxwell DL; Orian JM
    J Cent Nerv Syst Dis; 2023; 15():11795735231211508. PubMed ID: 37942276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-chain fatty acid producers in the gut are associated with pediatric multiple sclerosis onset.
    Schoeps VA; Zhou X; Horton MK; Zhu F; McCauley KE; Nasr Z; Virupakshaiah A; Gorman MP; Benson LA; Weinstock-Guttman B; Waldman A; Banwell BL; Bar-Or A; Marrie RA; van Domselaar G; O'Mahony J; Mirza AI; Bernstein CN; Yeh EA; Casper TC; Lynch SV; Tremlett H; Baranzini S; Waubant E;
    Ann Clin Transl Neurol; 2024 Jan; 11(1):169-184. PubMed ID: 37955284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune neuroinflammation newco.
    Nat Biotechnol; 2023 Oct; 41(10):1363. PubMed ID: 37828289
    [No Abstract]   [Full Text] [Related]  

  • 12. H
    Barnett JA; Gibson DL
    Gut Microbes; 2019; 10(3):261-269. PubMed ID: 30442070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significant impact of experimental variables on the gut microbiome.
    Zakarauskas-Seth BI; Sawamiphak S
    Cardiovasc Res; 2024 Jun; ():. PubMed ID: 38830015
    [No Abstract]   [Full Text] [Related]  

  • 14. Demyelinating and Neuroinflammatory Diseases of the Brain and the Spine.
    Forghani R; Srinivasan A
    Magn Reson Imaging Clin N Am; 2024 May; 32(2):xv-xvi. PubMed ID: 38555149
    [No Abstract]   [Full Text] [Related]  

  • 15. Welcome to Animal Microbiome.
    Huws SA
    Anim Microbiome; 2019 Feb; 1(1):1. PubMed ID: 33499922
    [No Abstract]   [Full Text] [Related]  

  • 16. Farnesol brain transcriptomics in CNS inflammatory demyelination.
    Doyle WJ; Walters D; Shi X; Hoffman K; Magori K; Roullet JB; Ochoa-Repáraz J
    Clin Immunol; 2023 Oct; 255():109752. PubMed ID: 37673223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiome Methods in Experimental Autoimmune Encephalomyelitis.
    Daberkow DP; Hoffman K; Kohl HM; Long T; Kirby TO; Ochoa-Repáraz J
    Curr Protoc; 2021 Dec; 1(12):e314. PubMed ID: 34870901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mining the microbiota to identify gut commensals modulating neuroinflammation in a mouse model of multiple sclerosis.
    Bianchimano P; Britton GJ; Wallach DS; Smith EM; Cox LM; Liu S; Iwanowski K; Weiner HL; Faith JJ; Clemente JC; Tankou SK
    Microbiome; 2022 Oct; 10(1):174. PubMed ID: 36253847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome.
    Al-Ghezi ZZ; Busbee PB; Alghetaa H; Nagarkatti PS; Nagarkatti M
    Brain Behav Immun; 2019 Nov; 82():25-35. PubMed ID: 31356922
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.